The global NSCLC Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for NSCLC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NSCLC Drugs.

Report Scope

The NSCLC Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NSCLC Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NSCLC Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of NSCLC Drugs Market Report

Report Metric	Details
Report Name	NSCLC Drugs Market
CAGR	5%
Segment by Type	Oral Type Injection Type
Segment by Application	Squamous Cell Lung Carcinoma Large-cell Lung Carcinoma
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Novartis, Jiangsu Hengrui Medicine, Innovent Biologics, Shanghai Junshi Biosciences, BeiGene, Roche, AstraZeneca, Pfizer, Boehringer-Ingelheim, Teva
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NSCLC Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the NSCLC Drugs Market report?

Ans: The main players in the NSCLC Drugs Market are Merck, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Novartis, Jiangsu Hengrui Medicine, Innovent Biologics, Shanghai Junshi Biosciences, BeiGene, Roche, AstraZeneca, Pfizer, Boehringer-Ingelheim, Teva

What are the Application segmentation covered in the NSCLC Drugs Market report?

Ans: The Applications covered in the NSCLC Drugs Market report are Squamous Cell Lung Carcinoma, Large-cell Lung Carcinoma

What are the Type segmentation covered in the NSCLC Drugs Market report?

Ans: The Types covered in the NSCLC Drugs Market report are Oral Type, Injection Type

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NSCLC Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Oral Type

1.2.3 Injection Type

1.3 Market by Application

1.3.1 Global NSCLC Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Squamous Cell Lung Carcinoma

1.3.3 Large-cell Lung Carcinoma

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global NSCLC Drugs Market Perspective (2019-2030)

2.2 NSCLC Drugs Growth Trends by Region

2.2.1 Global NSCLC Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 NSCLC Drugs Historic Market Size by Region (2019-2024)

2.2.3 NSCLC Drugs Forecasted Market Size by Region (2025-2030)

2.3 NSCLC Drugs Market Dynamics

2.3.1 NSCLC Drugs Industry Trends

2.3.2 NSCLC Drugs Market Drivers

2.3.3 NSCLC Drugs Market Challenges

2.3.4 NSCLC Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NSCLC Drugs Players by Revenue

3.1.1 Global Top NSCLC Drugs Players by Revenue (2019-2024)

3.1.2 Global NSCLC Drugs Revenue Market Share by Players (2019-2024)

3.2 Global NSCLC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by NSCLC Drugs Revenue

3.4 Global NSCLC Drugs Market Concentration Ratio

3.4.1 Global NSCLC Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NSCLC Drugs Revenue in 2023

3.5 NSCLC Drugs Key Players Head office and Area Served

3.6 Key Players NSCLC Drugs Product Solution and Service

3.7 Date of Enter into NSCLC Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 NSCLC Drugs Breakdown Data by Type

4.1 Global NSCLC Drugs Historic Market Size by Type (2019-2024)

4.2 Global NSCLC Drugs Forecasted Market Size by Type (2025-2030)

5 NSCLC Drugs Breakdown Data by Application

5.1 Global NSCLC Drugs Historic Market Size by Application (2019-2024)

5.2 Global NSCLC Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America NSCLC Drugs Market Size (2019-2030)

6.2 North America NSCLC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America NSCLC Drugs Market Size by Country (2019-2024)

6.4 North America NSCLC Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NSCLC Drugs Market Size (2019-2030)

7.2 Europe NSCLC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe NSCLC Drugs Market Size by Country (2019-2024)

7.4 Europe NSCLC Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NSCLC Drugs Market Size (2019-2030)

8.2 Asia-Pacific NSCLC Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific NSCLC Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific NSCLC Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NSCLC Drugs Market Size (2019-2030)

9.2 Latin America NSCLC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America NSCLC Drugs Market Size by Country (2019-2024)

9.4 Latin America NSCLC Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NSCLC Drugs Market Size (2019-2030)

10.2 Middle East & Africa NSCLC Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa NSCLC Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa NSCLC Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Detail

11.1.2 Merck Business Overview

11.1.3 Merck NSCLC Drugs Introduction

11.1.4 Merck Revenue in NSCLC Drugs Business (2019-2024)

11.1.5 Merck Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Detail

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb NSCLC Drugs Introduction

11.2.4 Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2019-2024)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 Regeneron Pharmaceuticals

11.3.1 Regeneron Pharmaceuticals Company Detail

11.3.2 Regeneron Pharmaceuticals Business Overview

11.3.3 Regeneron Pharmaceuticals NSCLC Drugs Introduction

11.3.4 Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2019-2024)

11.3.5 Regeneron Pharmaceuticals Recent Development

11.4 Novartis

11.4.1 Novartis Company Detail

11.4.2 Novartis Business Overview

11.4.3 Novartis NSCLC Drugs Introduction

11.4.4 Novartis Revenue in NSCLC Drugs Business (2019-2024)

11.4.5 Novartis Recent Development

11.5 Jiangsu Hengrui Medicine

11.5.1 Jiangsu Hengrui Medicine Company Detail

11.5.2 Jiangsu Hengrui Medicine Business Overview

11.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Introduction

11.5.4 Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2019-2024)

11.5.5 Jiangsu Hengrui Medicine Recent Development

11.6 Innovent Biologics

11.6.1 Innovent Biologics Company Detail

11.6.2 Innovent Biologics Business Overview

11.6.3 Innovent Biologics NSCLC Drugs Introduction

11.6.4 Innovent Biologics Revenue in NSCLC Drugs Business (2019-2024)

11.6.5 Innovent Biologics Recent Development

11.7 Shanghai Junshi Biosciences

11.7.1 Shanghai Junshi Biosciences Company Detail

11.7.2 Shanghai Junshi Biosciences Business Overview

11.7.3 Shanghai Junshi Biosciences NSCLC Drugs Introduction

11.7.4 Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2019-2024)

11.7.5 Shanghai Junshi Biosciences Recent Development

11.8 BeiGene

11.8.1 BeiGene Company Detail

11.8.2 BeiGene Business Overview

11.8.3 BeiGene NSCLC Drugs Introduction

11.8.4 BeiGene Revenue in NSCLC Drugs Business (2019-2024)

11.8.5 BeiGene Recent Development

11.9 Roche

11.9.1 Roche Company Detail

11.9.2 Roche Business Overview

11.9.3 Roche NSCLC Drugs Introduction

11.9.4 Roche Revenue in NSCLC Drugs Business (2019-2024)

11.9.5 Roche Recent Development

11.10 AstraZeneca

11.10.1 AstraZeneca Company Detail

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca NSCLC Drugs Introduction

11.10.4 AstraZeneca Revenue in NSCLC Drugs Business (2019-2024)

11.10.5 AstraZeneca Recent Development

11.11 Pfizer

11.11.1 Pfizer Company Detail

11.11.2 Pfizer Business Overview

11.11.3 Pfizer NSCLC Drugs Introduction

11.11.4 Pfizer Revenue in NSCLC Drugs Business (2019-2024)

11.11.5 Pfizer Recent Development

11.12 Boehringer-Ingelheim

11.12.1 Boehringer-Ingelheim Company Detail

11.12.2 Boehringer-Ingelheim Business Overview

11.12.3 Boehringer-Ingelheim NSCLC Drugs Introduction

11.12.4 Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2019-2024)

11.12.5 Boehringer-Ingelheim Recent Development

11.13 Teva

11.13.1 Teva Company Detail

11.13.2 Teva Business Overview

11.13.3 Teva NSCLC Drugs Introduction

11.13.4 Teva Revenue in NSCLC Drugs Business (2019-2024)

11.13.5 Teva Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Merck

Bristol–Myers Squibb

Regeneron Pharmaceuticals

Novartis

Jiangsu Hengrui Medicine

Innovent Biologics

Shanghai Junshi Biosciences

List of Tables

Table 1. Global NSCLC Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Oral Type

Table 3. Key Players of Injection Type

Table 4. Global NSCLC Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global NSCLC Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global NSCLC Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global NSCLC Drugs Market Share by Region (2019-2024)

Table 8. Global NSCLC Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global NSCLC Drugs Market Share by Region (2025-2030)

Table 10. NSCLC Drugs Market Trends

Table 11. NSCLC Drugs Market Drivers

Table 12. NSCLC Drugs Market Challenges

Table 13. NSCLC Drugs Market Restraints

Table 14. Global NSCLC Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global NSCLC Drugs Market Share by Players (2019-2024)

Table 16. Global Top NSCLC Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSCLC Drugs as of 2023)

Table 17. Ranking of Global Top NSCLC Drugs Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by NSCLC Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players NSCLC Drugs Product Solution and Service

Table 21. Date of Enter into NSCLC Drugs Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global NSCLC Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global NSCLC Drugs Revenue Market Share by Type (2019-2024)

Table 25. Global NSCLC Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global NSCLC Drugs Revenue Market Share by Type (2025-2030)

Table 27. Global NSCLC Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global NSCLC Drugs Revenue Market Share by Application (2019-2024)

Table 29. Global NSCLC Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global NSCLC Drugs Revenue Market Share by Application (2025-2030)

Table 31. North America NSCLC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America NSCLC Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America NSCLC Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe NSCLC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe NSCLC Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe NSCLC Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific NSCLC Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific NSCLC Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific NSCLC Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America NSCLC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America NSCLC Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America NSCLC Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa NSCLC Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa NSCLC Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa NSCLC Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 46. Merck Company Detail

Table 47. Merck Business Overview

Table 48. Merck NSCLC Drugs Product

Table 49. Merck Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 50. Merck Recent Development

Table 51. Bristol-Myers Squibb Company Detail

Table 52. Bristol-Myers Squibb Business Overview

Table 53. Bristol-Myers Squibb NSCLC Drugs Product

Table 54. Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 55. Bristol-Myers Squibb Recent Development

Table 56. Regeneron Pharmaceuticals Company Detail

Table 57. Regeneron Pharmaceuticals Business Overview

Table 58. Regeneron Pharmaceuticals NSCLC Drugs Product

Table 59. Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 60. Regeneron Pharmaceuticals Recent Development

Table 61. Novartis Company Detail

Table 62. Novartis Business Overview

Table 63. Novartis NSCLC Drugs Product

Table 64. Novartis Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 65. Novartis Recent Development

Table 66. Jiangsu Hengrui Medicine Company Detail

Table 67. Jiangsu Hengrui Medicine Business Overview

Table 68. Jiangsu Hengrui Medicine NSCLC Drugs Product

Table 69. Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 70. Jiangsu Hengrui Medicine Recent Development

Table 71. Innovent Biologics Company Detail

Table 72. Innovent Biologics Business Overview

Table 73. Innovent Biologics NSCLC Drugs Product

Table 74. Innovent Biologics Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 75. Innovent Biologics Recent Development

Table 76. Shanghai Junshi Biosciences Company Detail

Table 77. Shanghai Junshi Biosciences Business Overview

Table 78. Shanghai Junshi Biosciences NSCLC Drugs Product

Table 79. Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 80. Shanghai Junshi Biosciences Recent Development

Table 81. BeiGene Company Detail

Table 82. BeiGene Business Overview

Table 83. BeiGene NSCLC Drugs Product

Table 84. BeiGene Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 85. BeiGene Recent Development

Table 86. Roche Company Detail

Table 87. Roche Business Overview

Table 88. Roche NSCLC Drugs Product

Table 89. Roche Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 90. Roche Recent Development

Table 91. AstraZeneca Company Detail

Table 92. AstraZeneca Business Overview

Table 93. AstraZeneca NSCLC Drugs Product

Table 94. AstraZeneca Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 95. AstraZeneca Recent Development

Table 96. Pfizer Company Detail

Table 97. Pfizer Business Overview

Table 98. Pfizer NSCLC Drugs Product

Table 99. Pfizer Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 100. Pfizer Recent Development

Table 101. Boehringer-Ingelheim Company Detail

Table 102. Boehringer-Ingelheim Business Overview

Table 103. Boehringer-Ingelheim NSCLC Drugs Product

Table 104. Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 105. Boehringer-Ingelheim Recent Development

Table 106. Teva Company Detail

Table 107. Teva Business Overview

Table 108. Teva NSCLC Drugs Product

Table 109. Teva Revenue in NSCLC Drugs Business (2019-2024) & (US$ Million)

Table 110. Teva Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NSCLC Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global NSCLC Drugs Market Share by Type: 2023 VS 2030

Figure 3. Oral Type Features

Figure 4. Injection Type Features

Figure 5. Global NSCLC Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global NSCLC Drugs Market Share by Application: 2023 VS 2030

Figure 7. Squamous Cell Lung Carcinoma Case Studies

Figure 8. Large-cell Lung Carcinoma Case Studies

Figure 9. NSCLC Drugs Report Years Considered

Figure 10. Global NSCLC Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global NSCLC Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global NSCLC Drugs Market Share by Region: 2023 VS 2030

Figure 13. Global NSCLC Drugs Market Share by Players in 2023

Figure 14. Global Top NSCLC Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSCLC Drugs as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by NSCLC Drugs Revenue in 2023

Figure 16. North America NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America NSCLC Drugs Market Share by Country (2019-2030)

Figure 18. United States NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe NSCLC Drugs Market Share by Country (2019-2030)

Figure 22. Germany NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific NSCLC Drugs Market Share by Region (2019-2030)

Figure 30. China NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America NSCLC Drugs Market Share by Country (2019-2030)

Figure 38. Mexico NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa NSCLC Drugs Market Share by Country (2019-2030)

Figure 42. Turkey NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia NSCLC Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Merck Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 45. Bristol-Myers Squibb Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 46. Regeneron Pharmaceuticals Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 47. Novartis Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 48. Jiangsu Hengrui Medicine Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 49. Innovent Biologics Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 50. Shanghai Junshi Biosciences Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 51. BeiGene Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 52. Roche Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 53. AstraZeneca Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 54. Pfizer Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 55. Boehringer-Ingelheim Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 56. Teva Revenue Growth Rate in NSCLC Drugs Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions